322 related articles for article (PubMed ID: 17691999)
1. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
Jiménez P; García A; Santander S; Piazuelo E
Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
Patrignani P; Patrono C
Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
5. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
6. Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy.
Krishnan K; Brenner DE
Gastroenterol Clin North Am; 2001 Dec; 30(4):981-1000. PubMed ID: 11764539
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
Perini R; Fiorucci S; Wallace JL
Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
[TBL] [Abstract][Full Text] [Related]
8. Dual COX inhibition and upper gastrointestinal damage.
Skelly MM; Hawkey CJ
Curr Pharm Des; 2003; 9(27):2191-5. PubMed ID: 14529399
[TBL] [Abstract][Full Text] [Related]
9. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S; Kaidi A; Williams AC; Paraskeva C
Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
[TBL] [Abstract][Full Text] [Related]
10. Safety of anti-inflammatory treatment--new ways of thinking.
Brune K
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i16-20. PubMed ID: 14752171
[TBL] [Abstract][Full Text] [Related]
11. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.
Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
World J Gastroenterol; 2006 Mar; 12(9):1336-45. PubMed ID: 16552798
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.
Dannenberg AJ; Altorki NK; Boyle JO; Lin DT; Subbaramaiah K
Ann N Y Acad Sci; 2001 Dec; 952():109-15. PubMed ID: 11795429
[TBL] [Abstract][Full Text] [Related]
14. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based evaluation of the gastrointestinal safety of coxibs.
Bombardier C
Am J Cardiol; 2002 Mar; 89(6A):3D-9D. PubMed ID: 11909555
[TBL] [Abstract][Full Text] [Related]
16. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibition in upper aerodigestive tract tumors.
Altorki NK; Subbaramaiah K; Dannenberg AJ
Semin Oncol; 2004 Apr; 31(2 Suppl 7):30-6. PubMed ID: 15252927
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase inhibition in cancer prevention and treatment.
Anderson WF; Umar A; Hawk ET
Expert Opin Pharmacother; 2003 Dec; 4(12):2193-204. PubMed ID: 14640918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
